Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

v3.8.0.1
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended
Oct. 04, 2017
Mar. 31, 2018
Jan. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Number of common stock shares outstanding       35,272,626 31,745,242
Parent Company [Member]          
Number of common stock shares outstanding       246,907,902  
CoNCERT Pharmaceuticals, Inc [Member]          
Gross proceeds from equity or other financing $ 8,000,000        
Subsequent Event [Member]          
Percentage of sublicense revenue earned   15.00%      
Loss on cybersecurity fraud     $ 144,200    
Subsequent Event [Member] | Parent Company [Member]          
Percentage of sublicense revenue earned   0.00%      
Gross proceeds from equity or other financing   $ 8,000,000      
Sublicense revenue   8,000,000      
Subsequent Event [Member] | CoNCERT Pharmaceuticals, Inc [Member]          
Amount of common stock owned   $ 8,000,000      
Number of common stock shares outstanding   2,090,300      
Subsequent Event [Member] | Promet Therapeutics, LLC [Member]          
Common stock percentage   6.58%      
Common stock issued and outstanding percentage   5.93%